On April 11, 2023, Envista Holdings Corporation (the Company) and Jean-Claude Kyrillos, the Company's SVP and President, Diagnostics and Digital Solutions, mutually agreed that Mr. Kyrillos' employment will terminate effective June 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.03 USD | -1.21% | -1.31% | -25.06% |
05-28 | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
05-01 | Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Reports Q1 EPS $0.26, vs. Street Est of $0.32 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.06% | 3.14B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+3.49% | 40.74B | |
+19.92% | 31.6B | |
+16.38% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- NVST Stock
- News Envista Holdings Corporation
- Envista Holdings Corporation Announces Termination of Jean-Claude Kyrillos as SVP and President, Diagnostics and Digital Solutions, Effective June 30, 2023